Business, energy, technology, markets and global industry news from Business News Today
PharmaDeviceNews
Pharma & Biotech

Why Afrezza’s pediatric FDA approval could reshape mealtime insulin use in children with diabetes

Find out how Afrezza’s pediatric FDA approval could change mealtime insulin use for children with diabetes and MannKind’s growth story.

Read More
Representative image: A neurology consultation scene highlights the growing clinical focus on migraine prevention as Lundbeck’s bocunebart Phase IIb data strengthen interest in PACAP-targeted therapies for patients with hard-to-treat migraine.
Pharma & Biotech

Why Lundbeck’s anti-PACAP migraine drug could matter beyond another Phase II win

Find out how Lundbeck’s bocunebart Phase IIb data could reshape migraine prevention and test the PACAP pathway.

Read More
Crenessity two-year data highlight growing interest in long-term congenital adrenal hyperplasia treatment, steroid reduction, and endocrine outcomes. Representative image.
Pharma & Biotech

Neurocrine builds long-term case for Crenessity in congenital adrenal hyperplasia

See how Neurocrine’s two-year Crenessity data may reshape long-term classic CAH care, steroid reduction and pediatric outcomes.

Read More
Pharma & Biotech

Why Tempus’ tumor-only xT CDx approval could matter for precision oncology testing

Find out how Tempus’ tumor-only xT CDx FDA approval could expand precision oncology testing and reshape solid tumor profiling.

Read More
Pharma & Biotech

How Pharming’s Joenja resubmission could reopen the FDA pathway for pediatric APDS treatment

Find out how Pharming’s Joenja sNDA resubmission could reopen the FDA pathway for younger children with APDS.

Read More
Pharma & Biotech

Can L’Oréal-backed funding help OliX Pharmaceuticals turn siRNA science into a broader biotech platform?

Find out how OliX Pharmaceuticals’ KRW 110 billion raise could reshape RNAi therapeutics, beauty biotech, and siRNA platform strategy.

Read More
Representative image: A generic diagnostic test setup illustrates how blood-based lateral flow testing could support Ebola triage and treatment monitoring as VolitionRx advances patent protection for its Nu.Q NETs platform.
Medical Devices & Diagnostics

Why VolitionRx is positioning Nu.Q NETs beyond sepsis and into Ebola monitoring

Find out how VolitionRx’s Nu.Q NETs patent filing could reshape Ebola triage, outbreak diagnostics, and treatment monitoring.

Read More
Representative image of a modern connected healthcare clinic, illustrating Semble’s £30 million funding round and its push to expand digital health software across Europe.
Pharma & Biotech

Why Semble’s £30m Series C could reshape private healthcare software in Europe

Find out how Semble’s £30M Series C could reshape connected healthcare software and private clinic workflows across Europe.

Read More
Representative image of an intravenous antibiotic vial and sterile hospital laboratory setup, reflecting Wockhardt’s Zaynich FDA approval and India’s growing role in antimicrobial resistance innovation.
Pharma & Biotech

Can Zaynich help Wockhardt turn Indian antibiotic innovation into a global commercial platform?

Find out how Wockhardt’s Zaynich FDA approval could reshape Indian pharma innovation and the fight against drug-resistant infections.

Read More
Representative image of pharmaceutical quality control and drug manufacturing, reflecting Concord Biotech’s United States Food and Drug Administration approval for Mycophenolate Mofetil oral suspension and the market focus on its transplant immunosuppressant portfolio.
Pharma & Biotech

Can Mycophenolate Mofetil approval strengthen Concord Biotech’s United States generics strategy?

Find out how Concord Biotech’s FDA approval for Mycophenolate Mofetil could reshape its transplant generics strategy.

Read More